The Big Asthma Lie

Asthma Holistic Treatments

Get Instant Access



Airway obstruction

(' resistance to airflow)

Asthma, COPD. bronchiectasis (permanent dilation of airways with obliteration by secretions, infections, fibrosis), tumor or foreign body

Parenchymal disease

(t resistance to expansion)

Pulmonary edema cardiogenic: LV systolic or diastolic dysfxn noncardiogenic: ALI/ARDS ILD


(V/Q mismatch)

Large vessel: PE. tumor emboli

Small vessel: PHT. vasculitis. ILD. emphysema


(T resistance to CW/diaphragm expansion; weakness of respiratory muscles)

Pleural disease: effusion, fibrosis

Chest wall/diaphragm: kyphoscoliosis, i abd girth

Neuromuscular disorders

Hyperinflation (COPD. asthma)

Stimulation of receptors ; Oj carrying cap. (but nl P.Oj)

Chemoreceptors: hypoxemia, metabolic acidosis Mechanoreceptors: ILD. pulmonary edema. PHT. PE Anemia, methemoglobinemia. CO poisoning


Anxiety, panic attack, depression, somatization


• Cardiopulmonary exam. S,Oj. CXR. ECG

predictors of CHF: h/o CHF. PND. S). CXR w/ venous congestion. AF ^ama 2005:294:1944) dyspnea w/ nl CXR — CAD. asthma. PE. PHT. early ILD. anemia, acidosis. NM disease

• Based on results of initial evaluation: PFTs. chest CT.TTE. cardiopulmonary testing

• BNP & NT-proBNP t in CHF (but also t in AF. RV strain from PE. COPD flare. PHT)

BNP -100:90% Se. 76% Sp for CHF causing dyspnea (NijM 2002.347 161) NT-proBNP: >300 pg/mL - 99% Se. 60% Sp for CHF ( use 300 to rule out) to rule in use age-related cutpoints: >450 pg/mL if 50 y. 900 if 50-75 y. 1800 if ^75 y - 90% Se. 84% Sp (£HJ 2006:27:330) t in chronic heart failure, need to compare to known "dry BNP"


• Spirometry: evaluate for obstructive disease

Flow-volume loops: diagnose and/or localize obstruction

Bronchodilator: indicated if obstruction at baseline or asthma clinically suspected Methacholine challenge: helps dx asthma if spirometry nl. 20% i FEN^ — asthma

• Lung volumes: evaluate for restrictive disease including NM causes

• DlCO: evaluates functional surface area for gas exchange; helps differentiate causes of obstructive and restrictive diseases and screens for vascular disease & early ILD

Figure 2-1 Approach to abnormal PFTj

Approach to abnormal PFTs fev./fvc <0.75


TLC <80% predicted


FEV, response to bronchodil. 1

i dlco

FEV, response to bronchodil. 1

Abnl dt co w/ normal spirometry / \ 1 dlco t dlco

Asthma ILD Hemorrhage CHF Polycythemia t Pulm blood vol. (e.g.. obesity, mild CHF. L-»R shunts)

nl Dl co

/iPimax ij,

Pleural disease?


Was this article helpful?

0 0
Anxiety Away

Anxiety Away

The strategies revealed within Anxiety Away are fast acting, simple and guaranteed to work even if you have suffered from anxiety for a long time!

Get My Free Ebook

Post a comment